Pacira Pharmaceuticals reported $756.64M in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acelrx Pharmaceuticals ACRX:US $ -38.27M 2.38M
Aerie Pharmaceuticals AERI:US $ -141.13M 15.42M
Amerisourcebergen ABC:US $ 224.3M 326.01M
Astellas Pharma 4503:JP Y 1539052M 78744M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Cara Therapeutics CARA:US $ 204.11M 23.41M
Coherus Biosciences CHRS:US $ -22.63M 35.19M
Depomed DEPO:US $ 111.86M 9.45M
Endo International Ordinary Shares ENDP:US $ -1311M 67.01M
Heron Therapeutics HRTX:US $ 23.96M 53.61M
Horizon Pharma HZNP:US $ 4945.53M 127.7M
Ironwood Pharmaceuticals IRWD:US $ 532.88M 15.1M
JAZZ PHA JAZZ:US $ 3200.78M 407.71M
Lannett LCI:US $ -159.31M 33.15M
Ligand Pharmaceuticals LGND:US $ 793.19M 27.97M
Nektar Therapeutics NKTR:US $ 458.73M 149.16M
Omeros OMER:US $ -4925000 28.7M
Pacira Pharmaceuticals PCRX:US $ 756.64M 47.06M
Perrigo Ordinary Shares PRGO:US $ 5104.5M 47.2M
Revance Therapeutics RVNC:US $ 25.54M 42.93M
Supernus Pharmaceuticals SUPN:US $ 841.43M 12.99M
Teva Pharmaceutical TEVA:IT 9.04B 307M
Xeris Pharmaceuticals Inc XERS:US $ 96.46M 1.22M
Xoma XOMA:US $ 134.96M 4.97M
Zoetis ZTS:US $ 4580M 78M